Quantitative Systematic Strategies LLC Intellia Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$132.37 - $176.78 $230,985 - $308,481	-1,745 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$60.88 - $161.91 $1.12 Million - $2.99 Million	-18,472 Reduced 91.37%	1,745 $283,000
Q1 2021 May 06, 2021	BUY	$46.59 - $83.68 $652,027 - $1.17 Million	13,995 Added 224.93%	20,217 $1.62 Million
Q4 2020 Feb 09, 2021	BUY	$18.83 - $63.53 $117,160 - $395,283	6,222 New	6,222 $338,000

314

89.3M

686K

599K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.74B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.